Your browser doesn't support javascript.
loading
A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy.
Sato, Hiroaki; Sazuka, Tomokazu; Fujimoto, Ayumi; Kagitani, Sakurako; Arai, Takayuki; Goto, Yusuke; Imamura, Yusuke; Sakamoto, Shinichi; Ikeda, Jun-Ichiro; Ichikawa, Tomohiko.
Afiliación
  • Sato H; Department of Urology Chiba University Graduate School of Medicine Chiba Japan.
  • Sazuka T; Department of Urology Chiba University Graduate School of Medicine Chiba Japan.
  • Fujimoto A; Department of Urology Chiba University Graduate School of Medicine Chiba Japan.
  • Kagitani S; Department of Diagnostic Pathology Chiba University Graduate School of Medicine Chiba Japan.
  • Arai T; Department of Molecular Pathology Chiba University Graduate School of Medicine Chiba Japan.
  • Goto Y; Department of Urology Chiba University Graduate School of Medicine Chiba Japan.
  • Imamura Y; Department of Urology Chiba University Graduate School of Medicine Chiba Japan.
  • Sakamoto S; Department of Urology Chiba University Graduate School of Medicine Chiba Japan.
  • Ikeda JI; Department of Urology Chiba University Graduate School of Medicine Chiba Japan.
  • Ichikawa T; Department of Diagnostic Pathology Chiba University Graduate School of Medicine Chiba Japan.
IJU Case Rep ; 6(3): 185-189, 2023 May.
Article en En | MEDLINE | ID: mdl-37144081

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IJU Case Rep Año: 2023 Tipo del documento: Article Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IJU Case Rep Año: 2023 Tipo del documento: Article Pais de publicación: Australia